Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-05-18 Purchase | 2021-05-18 8:23 pm | Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner | 727,272 | $11 | $7,999,992 | 2,914,776 (Direct) | View |
| 2021-02-09 Purchase | 2021-02-09 6:04 pm | Bolt Biotherapeutics Inc. | BOLT | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha POWELL MICHAEL 10% Owner | 450,000 | $20 | $9,000,000 | 2,754,437 (Direct) | View |
| 2020-08-11 Purchase | 2020-08-12 9:04 pm | Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Director 10% Owner | 133,333 | $15 | $1,999,995 | 3,606,707 (Indirect) | View |
| 2020-07-28 Purchase | 2020-07-28 6:08 pm | Inozyme Pharma Inc. | INZY | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner | 437,500 | $16 | $7,000,000 | 2,028,308 (Direct) | View |
| 2020-06-30 Purchase | 2020-07-01 9:36 pm | Akouos Inc. | AKUS | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner | 58,823 | $17 | $999,991 | 1,515,073 (Direct) | View |
| 2020-06-01 Sale | 2020-06-03 8:20 pm | Iterum Therapeutics plc | ITRM | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner | 500,000 | $1.6242 | $812,080 | 1,226,514 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-09-12 9:16 pm | N/A 2034-08-06 | Bicara Therapeutics Inc. | BCAX | POWELL MICHAEL Director | 0 | $0 | 59,501 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 4:15 pm | N/A 2033-06-13 | Galera Therapeutics Inc. | GRTX | POWELL MICHAEL Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:05 pm | N/A 2032-06-14 | Galera Therapeutics Inc. | GRTX | POWELL MICHAEL Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-05-31 Disposition | 2022-05-31 10:14 am | N/A 2031-08-09 | Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Director | 70,030 | $0 | 0 (Direct) | View |
| 2021-08-09 Option Award | 2021-08-10 4:05 pm | N/A 2031-08-09 | Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-21 9:18 pm | N/A 2031-06-16 | Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Director | 10,030 | $0 | 10,030 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 6:39 pm | N/A 2031-06-15 | Galera Therapeutics Inc. | GRTX | POWELL MICHAEL Director | 13,179 | $0 | 13,179 (Direct) | View |
| 2021-05-18 Conversion | 2021-05-18 8:23 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner | 2,187,504 | $0 | 2,914,776 (Direct) | View |
Ownership | 2021-05-13 7:30 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner | 0 | $0 | 2,187,504 (Direct) | View |
| 2021-02-09 Conversion | 2021-02-09 6:04 pm | N/A N/A | Bolt Biotherapeutics Inc. | BOLT | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha POWELL MICHAEL 10% Owner | 2,304,437 | $0 | 2,754,437 (Direct) | View |
Ownership | 2021-02-04 8:59 pm | N/A N/A | Bolt Biotherapeutics Inc. | BOLT | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha POWELL MICHAEL 10% Owner | 0 | $0 | 2,304,437 (Direct) | View |
| 2020-11-10 Option Award | 2020-11-12 5:20 pm | N/A 2030-11-09 | Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Director 10% Owner | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-08-11 Conversion | 2020-08-12 9:04 pm | N/A N/A | Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Director 10% Owner | 28,371,348 | $0 | 3,606,707 (Indirect) | View |
Ownership | 2020-08-06 9:12 pm | N/A N/A | Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Director 10% Owner | 0 | $0 | 3,473,374 (Indirect) | View |
| 2020-07-28 Conversion | 2020-07-28 6:08 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner | 13,478,920 | $0 | 2,028,308 (Direct) | View |
Ownership | 2020-07-23 9:31 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL Katabi Maha 10% Owner | 0 | $0 | 1,590,808 (Direct) | View |
| 2020-06-30 Conversion | 2020-07-01 9:36 pm | N/A N/A | Akouos Inc. | AKUS | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner | 32,143,835 | $0 | 1,515,073 (Direct) | View |
Ownership | 2020-06-25 9:26 pm | N/A N/A | Akouos Inc. | AKUS | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner | 0 | $0 | 1,456,250 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-10 5:19 pm | N/A 2030-06-08 | Galera Therapeutics Inc. | GRTX | POWELL MICHAEL Director 10% Owner | 13,179 | $0 | 13,179 (Indirect) | View |
| 2020-01-21 Option Award | 2020-01-23 7:25 pm | N/A 2025-01-31 | Iterum Therapeutics plc | ITRM | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. POWELL MICHAEL 10% Owner | 1,750,000 | $1,750,000 | 1,750,000 (Direct) | View |